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OBJECTIVES We sought to compare clinical outcomes of elective percutaneous coronary intervention (PCI)
and primary PCI for ST-segment elevation myocardial infarction (STEMI) at a community
hospital without onsite cardiac surgery to those at a tertiary center with onsite cardiac surgery.
BACKGROUND Disagreement exists about whether hospitals with cardiac catheterization laboratories, but
without onsite cardiac surgery, should develop PCI programs. Primary PCI for STEMI at
hospitals without onsite cardiac surgery have achieved satisfactory outcomes; however, elective
PCI outcomes are not well defined.
METHODS A total of 1,007 elective PCI and primary PCI procedures performed from March 1999 to
August 2005 at the Immanuel St. Joseph’s Hospital–Mayo Health System (ISJ) in Mankato,
Minnesota, were matched one-to-one with those performed at St. Mary’s Hospital (SMH) in
Rochester, Minnesota. Strict protocols were followed for case selection and PCI program
requirements. Clinical outcomes (in-hospital procedural success, death, any myocardial infarction,
Q-wave myocardial infarction, and emergency coronary artery bypass surgery) and follow-up
survival were compared between groups.
RESULTS Among 722 elective PCIs, procedural success was 97% at ISJ compared with 95% at SMH
(p  0.046). Among 285 primary PCIs for STEMI, procedural success was 93% at ISJ and
96% at SMH (p  0.085). No patients at ISJ undergoing PCI required emergent transfer for
cardiac surgery. Survival at two years’ follow-up by treatment location was similar for patients
with elective PCI and primary PCI.
CONCLUSIONS Similar clinical outcomes for elective PCI and primary PCI were achieved at a community
hospital without onsite cardiac surgery compared with those at a tertiary center with onsite
cardiac surgery using a prospective, rigorous protocol for case selection and PCI program
requirements. (J Am Coll Cardiol 2006;47:1713–21) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.039Cardiology Foundation
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core than one million percutaneous coronary interventions
PCIs) are performed annually in the U.S. (1). With contem-
orary coronary stents and adjunctive pharmacotherapies, pro-
edural success has improved to 90% to 95% (2–4). Concom-
tantly, the rate of emergency coronary artery bypass surgery
CABG) stemming from a procedural complication has
ecreased markedly to 1% or less (5–7). Several hospitals
ith cardiac catheterization laboratories but without onsite
ardiac surgery have developed PCI programs and reported
atisfactory results in small patient cohorts (8–24), but widespread
doption of this health care delivery model is very controversial.
Guidelines for PCI published by the American College of
ardiology (ACC) and the American Heart Association
AHA) in 2005 explicitly addressed the issue of onsite cardiac
urgical back-up for elective PCI and primary PCI for ST-
egment elevation myocardial infarction (STEMI) (1). Perfor-
ance of elective PCI without onsite cardiac surgery was deemed
From the *Division of Cardiovascular Diseases, †Department of Health Sciences
esearch, Division of Biostatistics, and ‡Department of Health Sciences Research,
ivision of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota.
upported by the Mayo Foundation for Medical Education and Research.t
Manuscript received January 3, 2006; revised manuscript received January 31, 2006;
ccepted February 17, 2006.class III indication (i.e., not indicated). Primary PCI for STEMI
as classified as a class IIb indication provided that minimal
perator volumes (75 total PCIs per year and 11 primary
CIs per year) and institutional volumes are met (36 primary
CIs per year), as well as requiring a proven, tested plan for rapid
ransport to a nearby hospital with cardiac surgical capability.
Our hypothesis was that PCI procedures can be performed
afely without onsite cardiac surgery by following strict proto-
ols for case selection and PCI program requirements. We
eport our outcomes in the first 1,007 PCI procedures at a
ommunity hospital without onsite cardiac surgery compared
ith those obtained at a high-volume tertiary care facility with
ardiac surgical capability.
ETHODS
CI program: Immanuel St. Joseph’s Hospital–Mayo
ealth System. Immanuel St. Joseph’s Hospital–Mayo
ealth System (ISJ) is a 150-bed community hospital
ocated in Mankato, Minnesota, with a population service
egion of approximately 300,000. It has a fully equipped
ardiac catheterization laboratory (digital biplane acquisi-
ion system: Advantx LCN; General Electric, Fairfield,
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PCI Without Onsite Cardiac Surgery April 18, 2006:1713–21onnecticut) but does not have onsite cardiac surgical
apability. St. Mary’s Hospital (SMH), located 85 miles
way in Rochester, Minnesota, is the nearest tertiary care
acility with onsite cardiac surgery. Both ISJ and SMH are
art of a vertically and clinically integrated health care
elivery system with shared governance by the Mayo Clinic
nd Foundation.
We developed a PCI program at ISJ and started perform-
ng elective PCI and primary PCI for STEMI in March
999 and March 2000, respectively. We followed a prospec-
ive, rigorous protocol at ISJ for case selection for elective
CI and primary PCI for STEMI (Table 1). Case selection
rotocols were reviewed and approved by the Mayo Clinic
atheterization Laboratory Practice Committee. Informed
onsent was obtained from the patient and included a
iscussion of goals, benefits, and risks, as well as the
lternative of transfer to another facility for PCI with onsite
ardiac surgery.
As a quality assurance measure for this new model of
ealth care delivery, the catheterization laboratory at ISJ was
inked to SMH through a high-speed telemedicine link, a
edicated T3 fiberoptic line. This T3 line enables real-time
ransfer of angiographic and ultrasonographic images and
emodynamic data as well as audio and video images to
eview terminals at the catheterization laboratory and car-
iac surgery operating suites at SMH. The T3 line possesses
maximal data transfer rate of 45 megabits/s. Digital
ngiographic images can be transmitted in real time without
ppreciable delay by using a 6:1 compression algorithm, and
able 1. Case Selection Protocol at ISJ
lective PCI
1. For the first 12 months, only ACC/AHA type A and B1 lesions we
reviewed every quarter.
2. After the first 12 months, eligibility was expanded beyond ACC/AH
a. ISJ operator’s assessment that coronary anatomy may preclude easy
tortuosity, chronic total occlusion, ostial lesion involving left anter
poor coronary guide catheter support).
b. Planned use of rotational atherectomy or directional atherectomy d
c. Poor baseline left ventricular function that may require hemodynam
3. In the past 12 months, cases with a Mayo Clinic Risk Score 10 w
rimary PCI
1. Cases with cardiogenic shock refractory to vasopressors were not elig
2. Cases with persistent, refractory ventricular arrhythmias were not eli
Abbreviations and Acronyms
ACC  American College of Cardiology
AHA  American Heart Association
CABG  coronary artery bypass surgery
CI  confidence interval
ISJ  Immanuel St. Joseph’s Hospital–
Mayo Health System
MI  myocardial infarction
PCI  percutaneous coronary intervention
SMH  St. Mary’s Hospital
STEMI  ST-segment elevation myocardial infarction
TVR  target vessel revascularizationCC/AHA  American College of Cardiology/American Heart Association; ISJ  Imm
ntervention.ncompressed images are transmitted with a 30- to 60-s
elay depending on the length of the angiographic se-
uence. Lossy data compression at ratios6:1 decreases the
ensitivity and accuracy of detecting coronary angiographic
eatures (25). For the first 12 months of the PCI program,
n interventional cardiologist at SMH observed and pro-
ided real-time consultation for every elective PCI proce-
ure. After the first 12 months, telemedicine consultation
ith cardiology or cardiac surgery colleagues at SMH was
sed on an as-needed basis and at the discretion of the
perator at ISJ. Real-time review during PCI was rarely
sed after the first 12 months.
All operators performing PCI at ISJ received formal
nterventional training in U.S.-accredited programs and
aintained procedural volumes compliant with ACC/AHA
uidelines. All operators at ISJ were credentialed and
otated through the SMH catheterization laboratory on a
eriodic basis. Allied health staff at ISJ involved with PCI
atient care also received training at SMH. Staff at ISJ and
MH followed the same protocols for periprocedural and
ostprocedural patient care.
Immediate access to emergency cardiac surgery was en-
ured with a tested transport protocol, which included
ccess to three helicopters as well as ground ambulances for
rgent patient transfer with intra-aortic balloon pump
apability for hemodynamic support, if necessary. This
ransport system was available for all patient transfers at
ayo Clinic but was not solely developed for or dedicated
o the PCI program. In rare circumstances during which
nclement weather prohibited ambulance transport by air or
round, an elective PCI procedure at ISJ was delayed or
ancelled. We evaluated this system with unscheduled and
nrehearsed “test” cases and transport times of 60 min
ere reliably achieved.
ata sources and outcome measures. All patients under-
oing PCI at ISJ and SMH were followed prospectively
ccording to a well-established protocol, the Mayo Clinic
CI Registry (26). This database contains demographic,
linical, and angiographic data, as well as information on
atient outcomes during follow-up. An independent re-
iewer adjudicated clinical and angiographic data. All pa-
ients were interviewed in person or by telephone 6 and 12
ible for elective PCI at ISJ. Cases, outcomes, and adverse events were
pe A and B lesions to include all low-to-moderate risk cases except:
t deployment (including diffuse disease, severe calcification, severe
scending or left circumflex artery, degenerated saphenous vein graft, or
s.
pport with intra-aortic balloon pump or ventricular assist device.
t eligible for elective PCI at ISJ.
or primary PCI at ISJ.
for primary PCI at ISJ.re elig
A ty
sten
ior de
evice
ic su
ere no
ible f
gibleanuel St. Joseph’s Hospital–Mayo Health System; PCI  percutaneous coronary
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April 18, 2006:1713–21 PCI Without Onsite Cardiac Surgeryonths after PCI and yearly thereafter to assess major
dverse cardiovascular events. Records from subsequent
isits and hospitalizations were obtained for review with the
atient’s written informed authorization. In accordance
ith Minnesota statute, we excluded all patients who did
ot grant authorization for use of their medical records for
esearch. This study was approved by the institutional
eview boards of both institutions.
Data from this registry were electronically available and
sed to identify our study population, to assess patient and
rocedural characteristics, as well as to track patient out-
omes. The primary outcomes of interest included in-
ospital angiographic success and procedural success. Def-
nition of end points, including angiographic success,
rocedural success, and myocardial infarction, are listed in
able 2. Creatine kinase-MB fraction isoenzymes were
rawn before the procedure and every 8 h  3 after the
rocedure. Additional creatine kinase-MB fraction isoen-
ymes were drawn in the event of any clinical events
uspicious for myocardial ischemia. Emergency CABG was
efined as CABG performed within 24 h of PCI for a
rocedural-related complication.
tatistical analyses. We report continuous variables as
eans  standard deviation and categorical variables as fre-
uencies and percentages. Because of the observational study
esign, a matched cohort approach was used in analysis to
inimize confounding due to varying patient characteristics by
reatment facility. Each PCI procedure at ISJ was matched
ne-to-one with a SMH procedure. Matching was accom-
lished separately between primary PCIs and elective PCIs.
or primary PCIs, matching was based on procedure date
within 1 year), age (within 5 years), gender, a propensity score
ased on 32 covariates and 9 interactions, Mayo Clinic Risk
able 2. Definition of In-Hospital Clinical Outcomes
lective PCI
1. Angiographic success
a. 20% residual stenosis (stent-treated lesion) or
b. 50% residual stenosis (non–stent-treated lesion)
2. Procedural success  angiographic success without death, any MI, o
3. Any MI
a. Development of new Q waves in 2 contiguous leads or
b. If pre-procedure CK-MB is normal, then require CK-MB 3 U
c. If pre-procedure CK-MB is  ULN, then require both an increas
CK-MB was decreasing before the suspected recurrent MI
rimary PCI for STEMI
1) Angiographic success
a. 20% residual stenosis (stent-treated lesion) or
b. 50% residual stenosis (non–stent-treated lesion)
2) Procedural success  angiographic success without death, any recurr
3) Any recurrent MI
a. Within 24 h of qualifying MI, then require typical chest pain 20
contiguous leads or new LBBB or
b. After 24 h of qualifying MI, then require typical chest pain 20
leads or new LBBB or
c. After 24 h of qualifying MI, then require typical chest pain 20 m
documentation that CK-MB was decreasing before the suspectedABG  coronary artery bypass surgery; CK  creatine kinase; LBBB  left bundle bran
TEMI  ST-segment elevation myocardial infarction; ULN  upper limit of normal.core (27), congestive heart failure on presentation, previous
ABG, and number of diseased vessels. For elective PCIs,
atching was based on procedure date (within 1 year), age
within 5 years), the previously mentioned propensity score,
ayo Clinic Risk Score, prior PCI, any myocardial infarction
MI) within the previous seven days, renal disease (defined as
erum creatinine 3 mg/dl), number of diseased vessels,
urrent smoking status, ACC/AHA type B2 and C lesions,
nd metastatic cancer. This matching process was conducted
lectronically using a computer algorithm designed to reduce
he total (weighted) difference between groups in the matching
ariables sets (28,29).
Patient characteristics were compared between groups
sing t-tests and chi-square tests, as appropriate. We
sed the Wilcoxon rank-sum test to compare ordered
ategorical variables (for example, number of diseased
essels treated during PCI). Conditional logistic regres-
ion was used to compare in-hospital outcomes, account-
ng for the matched structure of the data. Survival free of
ardiac events during follow-up was estimated using the
aplan-Meier method and tested using a Cox regression
odel with separate baseline hazards for each ISJ and
MH matched patient pair. Because the matching was
ased on procedures, some patients at ISJ with multiple
rocedures were in the cohort more than once. The
urvival analysis included the earliest successful PCI of
he patients treated at ISJ. The survival analysis start
oint was defined as the day of discharge from the
ospital (in-hospital events were excluded). All statistical
ests were two-sided, and p values 0.05 were considered
ignificant. We used SAS version 9.1 (SAS Institute Inc.,
ary, North Carolina) for all analyses.
rgency CABG
or
K-MB of at least 50% over previous value and documentation that
I, or emergency CABG
and new or recurrent ST-segment elevation 0.10 mV in 2
nd new or recurrent ST-segment elevation 0.10 mV in 2 contiguous
nd both an increase in CK-MB of at least 50% over previous value and
ent MIr eme
LN
e in C
ent M
min
min a
in a
recurrch block; MI  myocardial infarction; PCI  percutaneous coronary intervention;
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PCI Without Onsite Cardiac Surgery April 18, 2006:1713–21ESULTS
total of 1,048 consecutive PCI procedures were per-
ormed on 908 patients at ISJ. In this report, we analyzed a
ohort of 1,007 PCI procedures at ISJ, including 722
lective PCIs performed from March 1999 to August 2005
nd 285 primary PCIs performed from March 2000 to
ugust 2005. Thirty procedures were excluded because
atients refused consent for research, and 11 procedures (4
lective PCIs and 7 primary PCIs) were excluded because a
uitable match was not available. There were no in-hospital
eaths or CABG among the 11 PCI procedures excluded
or no suitable match. These 1,007 PCI procedures from ISJ
ere matched one-to-one to SMH procedures from a
ohort of 8,622 PCIs performed during the same time
eriod at SMH. Median follow-up time was 22.6 and 24.5
onths for elective PCI patients at ISJ and SMH, respec-
ively. Median follow-up time was 30.6 and 32.0 months for
he primary PCI patients at ISJ and SMH, respectively.
The total volume of PCI procedures per year performed
t ISJ from 1999 to 2005 were as follows: 55 (1999;
Table 3. Elective PCI Clinical and Angiograph
Variable
Age, yrs
Male gender, n (%)
MI 1 to 7 days before procedure, n (%)
Canadian Cardiovascular Class 3, n (%)
Mayo Clinic Risk Score, median (Q1, Q3)
Diabetes, n (%)
Hypertension, n (%)
History of cholesterol 240 mg/dl, n (%)
Current smoker, n (%)
CHF on presentation, n (%)
CHF class IV, n (%)
History of CHF, n (%)
Prior MI, n (%)
Prior PCI, n (%)
Prior CABG, n (%)
Peripheral vascular disease, n (%)
History of stroke or TIA, n (%)
Renal disease (creatinine 3.0 mg/dl), n (%)
Metastatic cancer, n (%)
Left ventricular ejection fraction (mean)
Left ventricular ejection fraction 0.40, n (%)
Multivessel disease, n (%)
Type B2 or C lesion, n (%)
Type C lesion, n (%)
Maximum device size (mm)
Total number of vessels treated, n (%)
1
2
3
Number of stents placed
Glycoprotein IIb/IIIa use, n (%)
Vein graft intervention, n (%)
Multivessel disease defined as70% stenosis in the target ves
fraction was available in 68% of SMH and 76% of ISJ patie
CABG  coronary artery bypass surgery; CHF  cong
Health System; MI  myocardial infarction; PCI  percuta
transient ischemic attack.xtrapolated for 12 months), 137 (2000), 243 (2001), 158 m2002), 141 (2003), 223 (2004), and 221 (2005). The
umber of operators at ISJ varied from one to three during
he specified time period.
Clinical and angiographic characteristics for the 722
lective PCI procedures are shown in Table 3 according to
reatment site. By design, the two cohorts (ISJ vs. SMH)
ere similar in terms of age (65 years), gender distribution
approximately 70% men), diabetes (24%), congestive heart
ailure on presentation (5%), multivessel disease (61%), and
ther baseline characteristics. The ISJ cohort used more
tents per procedure (1.5 vs. 1.3) and had more frequent use
f glycoprotein IIb/IIIa inhibitors (76% vs. 45%) compared
ith the SMH cohort. The greater use of glycoprotein
Ib/IIIa inhibitors at ISJ was protocol-driven, with the
bjective of reducing acute and subacute thrombosis and
ther ischemic events.
Clinical and angiographic characteristics for the 285
rimary PCI procedures are shown in Table 4. The two
ohorts were similar in terms of age (63 years), gender
istribution (approximately 74% men), diabetes (approxi-
haracteristics
H (n  722) ISJ (n  722) p Value
4.9  12.5 64.9  12.7 0.97
6 (66%) 504 (70%) 0.11
8 (14%) 118 (16%) 0.14
5 (45%) 305 (42%) 0.29
.0 (3.0, 6.0) 4.0 (3.0, 6.0) 0.18
0 (24%) 176 (24%) 0.73
0 (69%) 496 (69%) 1.00
4 (82%) 475 (79%) 0.28
7 (21%) 165 (23%) 0.27
8 (5%) 39 (5%) 0.91
6 (1%) 8 (1%) 0.59
6 (8%) 61 (9%) 0.86
3 (39%) 248 (34%) 0.10
5 (34%) 244 (34%) 0.96
4 (12%) 74 (10%) 0.40
2 (10%) 86 (12%) 0.29
0 (11%) 69 (10%) 0.31
8 (2%) 18 (3%) 0.95
1 (2%) 11 (2%) 0.99
54  16 56  13 0.18
2 (13%) 74 (10%) 0.14
3 (62%) 429 (61%) 0.86
9 (38%) 268 (38%) 0.94
2 (16%) 116 (16%) 0.72
3.3  0.6 3.3  0.6 0.80
0.39
6 (90%) 636 (88%)
8 (9%) 83 (11%)
7 (1%) 3 (0%)
1.3  0.9 1.5  1.0 0.001
3 (45%) 548 (76%) 0.001
2 (3%) 24 (3%) 0.77
50% stenosis in the other vessels. Left ventricular ejection
heart failure; ISJ  Immanuel St. Joseph’s Hospital–Mayo
coronary intervention; SMH St. Mary’s Hospital; TIA ic C
SM
6
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April 18, 2006:1713–21 PCI Without Onsite Cardiac Surgeryharacteristics. Intra-aortic balloon pump use was similar at
SJ and SMH (2% vs. 1%). The ISJ cohort had a higher
requency of left ventricular ejection fraction0.40 (27% vs.
1%) compared with SMH. Utilization of glycoprotein
Ib/IIIa inhibitors was similar for ISJ and SMH procedures
t 86% and 83%, respectively.
linical outcomes in elective PCI. In-hospital clinical
utcomes for elective PCI procedures are shown in Table 5
ccording to treatment site. Procedural success was 97% at
SJ (95% confidence interval [CI] 96% to 98%) and 95% at
MH (p  0.046). In-hospital death, any MI, and emer-
ency CABG after elective PCI were rare and similar
etween ISJ and SMH. Postprocedural Q-wave MI was
igher at SMH compared with ISJ (1% vs. 0%, p  0.019).
nly two (0.3%) in-hospital deaths occurred at ISJ and one
0.1%) in-hospital death occurred at SMH (p  0.56). At
SJ, the first death was a patient who underwent successful
tenting of both the left anterior descending and left
ircumflex arteries 10 days after anterior wall MI. Two days
fter PCI, the patient suffered a large embolic stroke, and
chocardiography documented a left ventricular thrombus
ssociated with an akinetic anterior wall. The family decided
do-not-resuscitate code status, and the patient died. The
Table 4. Primary PCI Clinical and Angiograph
Variable
Age, yrs
Male gender, n (%)
Mayo Clinic Risk Score, median (Q1, Q3)
Diabetes, n (%)
Hypertension, n (%)
History of cholesterol 240 mg/dl, n (%)
Current smoker, n (%)
CHF on presentation, n (%)
CHF class IV, n (%)
History of CHF, n (%)
Prior MI, n (%)
Prior PCI, n (%)
Prior CABG, n (%)
Peripheral vascular disease, n (%)
History of stroke or TIA, n (%)
Renal disease (creatinine 3.0 mg/dl), n (%)
Metastatic cancer, n (%)
Intra-aortic balloon pump, n (%)
Left ventricular ejection fraction (mean)
Left ventricular ejection fraction 0.40, n (%)
Multivessel disease, n (%)
TIMI flow grade 0 or 1 pre-procedure, n (%)
Maximum device size (mm)
Total number of vessels treated, n (%)
1
2
3
Number of stents placed
Glycoprotein IIb/IIIa use, n (%)
Vein graft intervention, n (%)
Multivessel disease defined as70% stenosis in the target ves
fraction was available in 41% of SMH and 93% of ISJ patie
CABG  coronary artery bypass surgery; CHF  cong
Health System; MI  myocardial infarction; PCI  percutan
transient ischemic attack; TIMI  Thrombolysis In Myocarecond death occurred in a patient who had successful atenting of a left anterior descending artery and diagonal
ranch bifurcation lesion who subsequently developed re-
piratory failure. Patient and family declined intubation/
entilator support. No patients at ISJ required emergency
ransfer for cardiac surgery. At SMH, the only death
ccurred in a patient who had previous CABG and chronic
enal failure requiring hemodialysis. The patient had a
rug-eluting stent placed in the right posterior descending
rtery for in-stent restenosis of a prior bare-metal stent. Six
ays after the procedure, the patient suffered an acute
nterior wall MI with cardiogenic shock and could not be
esuscitated. One patient at SMH required emergency
ABG related to the procedure. This patient experienced
erforation of the left anterior descending artery associated
ith cardiac tamponade. Immediate pericardiocentesis was
erformed; however, covered stent grafts were not available
n 2001, and the patient underwent successful emergency
ardiac surgery.
The Kaplan-Meier estimated probabilities of survival and
f remaining free from recurrent MI or target vessel
evascularization (TVR) during a median follow-up of 22.6
onths are shown in Figures 1A and 1B, respectively.
reatment location (ISJ vs. SMH) was not significantly
haracteristics
H (n  285) ISJ (n  285) p Value
3.3  12.9 63.1  13.1 0.80
8 (73%) 210 (74%) 0.85
.0 (6.0, 9.0) 8.0 (6.0, 10.0) 0.79
9 (21%) 49 (17%) 0.28
8 (64%) 151 (55%) 0.03
8 (75%) 109 (53%) 0.001
9 (39%) 93 (33%) 0.13
0 (7%) 18 (6%) 0.74
0 (4%) 9 (3%) 0.82
6 (10%) 21 (7%) 0.27
4 (15%) 62 (22%) 0.05
1 (14%) 45 (16%) 0.64
0 (4%) 9 (3%) 0.82
1 (8%) 24 (9%) 0.67
2 (8%) 22 (8%) 0.96
2 (1%) 4 (1%) 0.40
4 (1%) 3 (1%) 0.72
4 (1%) 6 (2%) 0.52
49  16 50  14 0.55
0 (11%) 76 (27%) 0.001
8 (69%) 191 (68%) 0.77
7 (60%) 187 (66%) 0.22
3.4  0.6 3.4  0.6 0.74
0.06
1 (92%) 272 (95%)
3 (8%) 13 (5%)
1 (0%) 0 (0%)
1.4  1.0 1.5  1.1 0.19
6 (83%) 246 (86%) 0.25
4 (1%) 4 (1%) 1.00
50% stenosis in the other vessels. Left ventricular ejection
heart failure; ISJ  Immanuel St. Joseph’s Hospital–Mayo
coronary intervention; SMH  St. Mary’s Hospital; TIA 
farction.ic C
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PCI Without Onsite Cardiac Surgery April 18, 2006:1713–21emaining free of recurrent MI or TVR (p 0.75). Survival
t one year and two years after elective PCI was 97% (14
eaths) and 94% (23 deaths), respectively, for patients
reated at ISJ compared with 97% (14 deaths) and 95% (22
eaths) for patients treated at SMH, respectively.
linical outcomes in primary PCI. In-hospital clinical
utcomes for primary PCI procedures also are shown in
able 5. Procedural success was 93% at ISJ (95% CI 90% to
6%) and 96% at SMH (p  0.085). In-hospital any
ecurrent MI, recurrent Q-wave MI, and emergency CABG
fter primary PCI were rare, and their rates were similar at
SJ and SMH. In-hospital deaths occurred in 10 (4%)
atients at ISJ compared with 4 (1%) patients at SMH (p
.050). Among the 10 deaths at ISJ, three patients died
rom respiratory failure related to severe chronic obstructive
ulmonary disease, one patient died from respiratory failure
elated to pulmonary hemorrhage in the setting of severe
hronic obstructive pulmonary disease and abciximab use,
ne patient died after ventilator support was withdrawn
ecause there was no neurologic recovery after a prolonged
ut-of-hospital cardiac arrest associated with the index MI,
wo patients died from progressive shock and were not
andidates for CABG because of patient and family deci-
ion, one patient had acute mitral regurgitation from a
uptured papillary muscle and was not a candidate for
ABG because of patient and family decision, one patient
uffered free-wall rupture after the procedure and could not
e resuscitated, and one patient had ventricular fibrillation
fter the procedure and could not be resuscitated. No
atients at ISJ or SMH required emergency CABG for a
rocedural-related complication.
The Kaplan-Meier estimated probabilities of survival and
f remaining free from recurrent MI or TVR during a
edian follow-up of 30.6 months are shown in Figures 2A
Table 5. In-Hospital Clinical Outcomes
Variable SM
Angiographic success, n (%)
Procedural success, n (%)
In-hospital death, n (%)
Any in-hospital MI, n (%)
In-hospital Q-wave MI, n (%)
In-hospital emergency CABG, n (%)
Variable SM
Angiographic success, n (%)
Procedural success, n (%)
In-hospital death, n (%)
Any recurrent in-hospital MI, n (%)
Recurrent in-hospital Q-wave MI, n (%)
In-hospital emergency CABG, n (%)
Angiographic success defined as 20% residual stenosis (st
lesion). Procedural success defined as angiographic success a
Abbreviations as in Table 4.nd 2B, respectively. Treatment location (ISJ vs. SMH) was sot significantly associated with survival during follow-up
p  0.84) or remaining free of recurrent MI or TVR (p 
.30). Survival at one year and two years after primary PCI
as 96% (8 deaths) and 94% (11 deaths), respectively, for
atients treated at ISJ compared with 96% (10 deaths) and
3% (15 deaths), respectively, for patients treated at SMH.
ISCUSSION
e systematically developed a PCI program at ISJ, a commu-
ity hospital with a catheterization laboratory but without
nsite cardiac surgery. Main features of the program were
ross-training and cross-credentialing of all operators, a tele-
edicine link for consultation, and strict protocols for case
election and PCI program requirements. Our objective was to
ompare clinical outcomes associated with performing elective
CI and primary PCI at ISJ to those obtained at SMH, a
ertiary center with onsite cardiac surgical capability. For
lective PCI, procedural success (97% vs. 95%, p 0.046) was
tatistically better at ISJ compared with SMH and in-hospital
eath (0.3% vs. 0.1%, p 0.56) was similar. We would caution
hat this observed difference in procedural success, albeit
tatistically significant, may not be clinically relevant. A
atched cohort analysis is not a substitute for a randomized
ontrolled trial, and our matching may not have adjusted for
esidual non-measured, non-quantified variables. For primary
CI, procedural success (93% vs. 96%, p 0.085) was similar
t ISJ compared with SMH, and in-hospital death (4% vs. 1%,
 0.050) was statistically higher at ISJ. The majority of
eaths observed at ISJ for primary PCI were not related to a
rocedural complication or absence of onsite cardiac surgery.
o patients at ISJ undergoing elective PCI or primary PCI
equired emergent transfer for cardiac surgery. Our results
uggest that elective PCI and primary PCI can be performed
Elective PCI
n  722) ISJ (n  722) p Value
(98%) 717 (99%) 0.035
(95%) 701 (97%) 0.046
(0.1%) 2 (0.3%) 0.56
(3%) 15 (2%) 0.27
(1%) 0 (0%) 0.019
(0.1%) 0 (0%) 0.24
Primary PCI
n  285) ISJ (n  285) p Value
(98%) 280 (98%) 0.76
(96%) 266 (93%) 0.085
(1%) 10 (4%) 0.050
(0.4%) 4 (1%) 0.17
(0.4%) 2 (1%) 0.56
(0%) 0 (0%) —
eated lesion) or 50% residual stenosis (non–stent-treated
hout in-hospital death, any MI, or emergency CABG.H (
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April 18, 2006:1713–21 PCI Without Onsite Cardiac Surgerytrict protocols for case selection and PCI program require-
ents are followed (Tables 1 and 6).
There is considerable disagreement about whether hospitals
ith cardiac catheterization laboratories, but without onsite
ardiac surgery, should develop PCI programs (30–34). Op-
osing viewpoints have debated trade-offs between quality and
utcomes versus convenience, cost implications for an institu-
ion versus the health care system, perceived versus real barriers
o access, and patient-centered versus financial and political
otives. Concerns raised against proliferation of PCI pro-
rams without onsite cardiac surgery argue that low-volume
rograms may result in poor outcomes as well as dilute
rocedural volume at current, high-volume institutions. Con-
ern exists that patients are not provided sufficient information
o evaluate whether a trade-off exists between convenience
ersus the quality and cost of the care they receive. Moreover,
igure 1. Kaplan-Meier curves relating treatment location to (A) survival
nd to (B) freedom from recurrent myocardial infarction (MI) or target
essel revascularization (TVR) for matched patients undergoing elective
ercutaneous coronary intervention. ISJ  Immanuel St. Joseph’s Hospi-
al–Mayo Health System; SMH  St. Mary’s Hospital.ommunity hospitals face competitive and market pressures to
p
tffer comprehensive cardiovascular services and improve finan-
ial performance.
On the other hand, previous studies have shown that
rimary PCI for STEMI achieves similar outcomes at hospi-
als with or without cardiac surgery if performed in a timely
anner and by experienced operators and institutions (17,24).
erforming primary PCI at community hospitals may benefit
atients who are not eligible for thrombolysis or who experi-
nce significant delays for transport to a hospital with onsite
ardiac surgery. Because it will be difficult for operators and
ospitals to maintain adequate volumes performing solely
rimary PCI, some community hospitals have expanded to
erforming low-risk elective PCI. Developing PCI programs
ithout onsite cardiac surgery may also improve access to care
or patients living in medically underserved regions or who face
eographic or socioeconomic barriers to access at tertiary
acilities. Patients also may prefer to be treated at facilities
igure 2. Kaplan-Meier curves relating treatment location to (A) survival
nd to (B) freedom from recurrent myocardial infarction (MI) or target
essel revascularization (TVR) for matched patients undergoing primary
ercutaneous coronary intervention. ISJ  Immanuel St. Joseph’s Hospi-
al–Mayo Health System; SMH  St. Mary’s Hospital.
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PCI Without Onsite Cardiac Surgery April 18, 2006:1713–21loser to home; furthermore, transferring patients to another
ospital may incur errors from poor communication of medical
nformation as well as increased costs if unnecessary tests are
epeated (30,31).
Wennberg et al. (35) compared in-hospital and 30-day
ortality for PCIs performed in Medicare enrollees (Medicare
rovider Analysis and Review claims database) older than 65
ears of age at hospitals with and without onsite cardiac
urgery. For primary PCI, there was no difference in the
djusted mortality among hospitals without and with onsite
ardiac surgery (11.3% vs. 12.2%, respectively, p  0.34). For
lective PCI, the adjusted mortality was 38% higher at hospi-
als without onsite cardiac surgery compared to those with
nsite cardiac surgery (4.6% vs. 2.8%, respectively, p 0.001).
owever, the observed increase in mortality for elective PCI
as confined to low volume hospitals that performed fewer
han 50 PCIs per year. Among the 10% of hospitals without
nsite cardiac surgery with an annual volume of50 PCIs per
ear, the observed mortality for elective PCI was similar
ithout or with onsite cardiac surgery (adjusted odds ratio
.04, 95% CI 0.76 to 1.41, p  0.83).
The important relationship between operator/hospital vol-
me and PCI outcomes has been documented by multiple
nvestigators (36–42). The 2005 ACC/AHA PCI Guidelines
rovide class I recommendations for minimal operator volume
75 total PCIs per year and 11 primary PCIs per year) as
ell as minimal hospital volume (400 total PCIs per and
36 primary PCIs per year) for a high-volume institution (1).
or a low-volume institution, the class IIa recommendation is
or a hospital volume of 200 total PCIs per year.
The rationale for the ACC/AHA PCI Guidelines’ cur-
ent recommendation of onsite cardiac surgery for elective
CI is based on two assumptions: 1) immediate availability
o cardiac surgery for hemodynamic or ischemic complica-
ions resulting from PCI, and 2) a surrogate measure of an
nstitution’s overall capability to provide appropriate care for
mergency scenarios in the cardiac catheterization labora-
ory (1). However, efficacy and safety of performing elective
nd primary PCI are not simply related to the availability of
nsite cardiac surgery per se; rather, they are more likely
ssociated with the staff, infrastructure, and processes to
rovide the service. To ensure optimal quality and clinical
utcomes, we recommend standard prerequisites for devel-
able 6. Requirements for a PCI Program Without Onsite Card
. Experienced operators and team that perform minimal volumes. (Oper
36 primary PCIs per year).
. Operator is “cross”-trained, “cross”-credentialed, and “cross”-practicing
. Well-equipped cardiac catheterization laboratory with a digital imaging
balloon pump for hemodynamic support.
. Rigorous protocol for case selection (low-to-moderate lesion risk and c
institutional practice committees.
. Proven, tested protocol for rapid ambulance transport for patients with
. Formal quality assurance process for data collection, analysis, and revie
standards.
CI  percutaneous coronary intervention.ping a PCI program without onsite cardiac surgery (Table S). Our results should not be used to justify proliferation of
ow-volume PCI programs without onsite cardiac surgical
apability. Conversely, we believe that health care systems
ust determine how best to concentrate their cognitive and
apital resources, including PCI programs, to provide the
afest and highest quality of care to a population.
tudy limitations. As an observational, matched cohort
nalysis, we adjusted for observed clinical and angiographic
ifferences between patient cohorts. However, we acknowl-
dge that unaccounted differences may remain that may
ave influenced our findings. Although we tested the
mergency transport system, no patients at ISJ actually
equired emergency cardiac surgery. Hence, we cannot
efinitively conclude that our transport system is adequate.
ur findings may not be generalizable and are restricted to
he experience of a single, high-volume referral center and a
ommunity hospital which are closely linked with regard to
linical care processes as well as the skill and training of
hysician and allied health staff.
onclusions. Comparable clinical outcomes for elective
CI and primary PCI for STEMI can be achieved at a
ommunity hospital without onsite cardiac surgery and a
ertiary care facility with onsite cardiac surgery. These
esults were obtained by developing and following strict
rotocols for case selection (Table 1) and PCI program
equirements (Table 6). Additional research is warranted to
ssess whether this model of healthcare delivery is general-
zable to other institutions and to study healthcare policy
mplications of where, when, and what PCI services
should” be provided to optimize quality, access, and cost for
ur patients.
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